Phio Pharmaceuticals Financials - Benzinga

SPY765.80+0.02%QQQ737.05+0.07%BTC/USD82,937.09−0.62%DIA514.14+0.02%GLD378.31+0.11%TLT78.69+0.09%

Phio Pharmaceuticals Corp

PHIONASDAQ

Trade with Public

Trade with Public

$1.01

N/A

At close: Sep 28, 5:00 PM EST

$1.00

-0.0068-0.67%

After Hours: 4:46 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Phio Pharmaceuticals Financials

Phio Pharmaceuticals (PHIO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Phio Pharma Q1 EPS $(0.34) Misses $(0.23) Estimate

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.23) by 47.83 percent. This is a 27.66 percent increase over losses of $(0.47) per share from the

Benzinga Newsdesk

PRO
Phio Pharma Q4 EPS $(0.15) Beats $(0.41) Estimate

Benzinga Newsdesk

PRO
Phio Pharma Q3 EPS $(0.44) Misses $(0.40) Estimate

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.40) by 10 percent. This is a 71.43 percent increase over losses of $(1.54) per share from the

Benzinga Newsdesk

PRO
Phio Pharma Q2 EPS $(0.45) Misses $(0.36) Estimate

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.36) by 25 percent. This is a 87.57 percent increase over losses of $(3.62) per share from the

Benzinga Newsdesk

PRO
Phio Pharma Q1 EPS $(0.47) Down From $(0.41) YoY

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.47) per share. This is a 14.63 percent decrease over losses of $(0.41) per share from the same period last year.

Benzinga Newsdesk

Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results

Avi Kapoor

© 2026 Benzinga | All Rights Reserved